Recent research led by Dumet, Kenzie, and Merino explores the policy and institutional determinants that influence the control and prevention of zoonoses in low-resource contexts. Their findings highlight the importance of understanding the multifaceted nature of zoonotic disease transmission and the economic, social, and political factors that play a critical role in shaping health outcomes. This comprehensive study sheds light on the mechanisms by which zoonoses propagate and offers insights into effective intervention strategies.

One of the key issues examined in the study is the insufficient coordination among different sectors involved in health management. In many low-resource settings, the veterinary, environmental, and public health sectors operate in silos, leading to fragmented responses to zoonotic threats. This lack of collaboration can result in delayed interventions and missed opportunities for early detection and prevention. The authors argue that breaking down these barriers is essential for achieving a unified response to zoonoses and ensuring that all relevant stakeholders are engaged in health promotion efforts.

Furthermore, the research emphasizes the role of political will and policy frameworks in shaping the landscape of zoonotic disease management. The authors point out that effective governance structures are critical in allocating resources, implementing preventive measures, and ensuring compliance with health regulations. In many regions, however, political instability and competing priorities can hinder progress, ultimately exacerbating the burden of zoonoses. Their analysis calls for international support and collaboration to strengthen governance and build resilient health systems.

The study also highlights the need for capacity building at all levels of health care systems. Training healthcare workers, veterinarians, and community health agents in the principles of One Health is essential to enhance local responses to zoonotic diseases. By fostering a deeper understanding of the interconnections between human and animal health, these professionals can better identify risk factors and implement strategic interventions tailored to their unique contexts.

Economic considerations are another critical dimension addressed by the authors. The burden of zoonotic diseases often falls disproportionately on low-income populations, who may lack access to adequate healthcare and preventative measures. The downstream effects of zoonoses can cripple already fragile economies, creating a vicious cycle of poverty and ill health. The research underscores the need for investment in public health infrastructure as a means of mitigating the socio-economic impacts of these diseases.

Public awareness and education are pivotal in controlling zoonotic diseases. The study suggests that community engagement and informed public can play significant roles in prevention efforts. Educational campaigns that raise awareness about zoonotic diseases and their transmission pathways can empower individuals to take preventive measures, such as improving hygiene practices and advocating for better animal health care. This grassroots approach can significantly enhance community resilience and responsiveness to zoonotic threats.

Importantly, the authors stress that innovative technologies and research are crucial in the fight against zoonoses. Surveillance systems that leverage artificial intelligence and big data can provide real-time insights into disease patterns, enabling timely interventions. Advances in biotechnology also offer potential pathways for developing vaccines and diagnostics tailored to specific zoonotic pathogens. Integrating these technological solutions with traditional practices can lead to more effective disease management strategies.

As the study advocates for a holistic approach to health governance, it also acknowledges the challenges posed by climate change and environmental degradation. These factors can exacerbate the emergence and re-emergence of zoonoses by altering habitats and animal behaviors. Addressing the environmental determinants of health is therefore imperative for sustainable health outcomes. Policies that promote environmental conservation and sustainable agricultural practices can play a pivotal role in mitigating the pressures that drive zoonotic disease emergence.

In conclusion, Dumet, Kenzie, and Merino’s research provides a comprehensive overview of the critical factors influencing zoonotic disease management in low-resource settings. By advocating for a One Health approach, the study not only highlights the interconnected nature of health systems but also offers practical recommendations for improving disease control efforts. As we navigate an increasingly complex health landscape, embracing integrative strategies will be key to safeguarding human, animal, and environmental health. The call for action is clear: we must prioritize collaboration, innovation, and community engagement to build resilient health systems capable of addressing the challenges presented by zoonoses.

In summary, the importance of the One Health approach cannot be overstated, as it recognizes the intricate links between diverse health domains. Effective zoonoses management demands a synergy of policies, practices, and stakeholder engagement that transcends traditional disciplinary boundaries. As health threats continue to evolve, our responses must adapt and innovate to protect the well-being of all populations.

Subject of Research: The policy and institutional determinants to control and prevent zoonoses in low-resource settings.

Article Title: Applying the One Health approach to study the policy and institutional determinants to control and prevent zoonoses in a low-resource setting.

Article References:

Dumet, L., Kenzie, E.S., Merino, V. et al. Applying the One Health approach to study the policy and institutional determinants to control and prevent zoonoses in a low-resource setting.
Health Res Policy Sys 23, 148 (2025). https://doi.org/10.1186/s12961-025-01408-7

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12961-025-01408-7

Keywords: One Health, zoonoses, public health, policy determinants, low-resource settings, disease prevention.

Fungal infections present a significant health burden worldwide, often causing diseases that range from mild to life-threatening, particularly in immunocompromised patients. The economic consequences are immense, with healthcare costs skyrocketing due to prolonged treatments and hospitalizations. In agriculture, fungicides are essential in safeguarding crops from fungal diseases that can devastate food supplies. However, the overlap between agricultural fungicides and medical antifungal drugs means that fungi exposed to pesticides in the environment may develop cross-resistance, which undermines the effectiveness of clinical treatments. This phenomenon is particularly concerning because the arsenal of available antifungal drugs is already limited compared to antibiotics.

Dr. George Thompson, the lead author of the commentary and a professor at UC Davis School of Medicine, underscores the parallel between antifungal resistance and the well-documented rise in antibiotic resistance fueled by antibiotic overuse in livestock. “The lessons learned from antibacterial resistance emphasize the importance of cautious and judicious use of antimicrobial agents,” Thompson remarks. Fungal organisms, like Candida auris, have cellular machinery that closely resembles human cells, which complicates the development of antifungals that selectively target fungi without harming patients. Hence, preventing the emergence of resistance is critical to retaining the efficacy of existing drugs.

The “One Health” framework advocated by Thompson and Desai urges a holistic perspective that recognizes the interconnectedness of ecosystems. Human health cannot be extricated from the health of animals or the environment, especially when considering the spread of fungal pathogens and their resistance profiles. Environmental factors such as climate change and shifting wind patterns also facilitate the dissemination of fungi across geographic boundaries, exacerbating the problem. Human travel and the migration of animals further complicate containment efforts by transporting resistant strains to new locations, creating new epidemiological hotspots.

Among the concerning pathogens, Candida auris stands out as an exemplar of the growing problem of antifungal resistance. Notorious for causing invasive infections that are difficult to treat, C. auris often exhibits multidrug resistance. The limited number of antifungal classes approved for clinical use means that resistance emergence significantly narrows therapeutic options. Furthermore, these drugs often provoke adverse effects in patients due to the similarity between fungal and human cells, highlighting the critical need for stewardship and innovation.

Central to the commentary is a call for tighter global regulation and collaboration in pesticide and antifungal drug development. The authors warn that resistance is strongly influenced by the scale and intensity of antimicrobial use. Therefore, a shared international framework that rigorously evaluates new compounds for their potential impacts on human, animal, and environmental health is imperative. This framework would ideally precede the widespread introduction of any new agricultural pesticides, preventing the inadvertent selection of resistant fungal strains in the environment.

Dr. Angel Desai, co-author and associate professor in the Department of Internal Medicine at UC Davis, stresses the necessity for a unified antimicrobial approval mechanism. Such a system would incorporate environmental safety assessments alongside traditional pharmaceutical evaluations, ensuring that new agents do not undermine medical treatments. She points out that this process would be instrumental in harmonizing the approach to mitigating resistance risks, benefiting regulatory bodies and stakeholders worldwide.

The commentary also highlights the formation of the Interagency Drug and Pesticide Resistance and Efficacy Workgroup under the U.S. Environmental Protection Agency (EPA). This group plays a critical role in scrutinizing proposed pesticide registrations with an eye toward their implications for medical practice. The hope expressed by the authors is for the emergence of analogous collaborations at the global level, allowing for shared expertise and coordinated action to stem the tide of antifungal resistance.

Beyond regulatory measures, the importance of surveillance and research cannot be overstated. Continuous monitoring of resistance patterns and molecular mechanisms in fungal populations will provide vital data for tailoring interventions. Advancements in genomic technologies and bioinformatics enable more precise detection of resistance genes and tracking of pathogen spread. These tools empower researchers and public health officials to respond dynamically as fungal threats evolve.

Addressing the root causes of antifungal resistance also requires innovative scientific endeavors aimed at discovering novel antifungal compounds with unique modes of action. Given the close biological kinship between fungi and humans, drug development is fraught with challenges, requiring agents that can selectively target fungal-specific pathways. This underscores the need for cross-disciplinary collaborations, integrating microbiology, medicinal chemistry, environmental science, and clinical medicine to innovate sustainable solutions.

In summary, the emerging crisis of antifungal drug resistance is a complex, global issue intricately tied to environmental stewardship, regulatory policy, and medical practice. The insightful commentary by UC Davis experts George Thompson and Angel Desai reinforces that only through a comprehensive “One Health” approach, encompassing human, animal, and environmental health, can we hope to mitigate the dangers posed by resistant fungal pathogens. Coordinated global efforts to regulate, monitor, and innovate antifungal use and development are not just prudent but indispensable for safeguarding future generations.

Article Title: Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge

News Publication Date: 7-Jun-2025

Web References:
– https://health.ucdavis.edu/medmicro/Faculty_MR/Thompson/thompson_index_mr.html
– http://www.nejm.org/doi/full/10.1056/NEJMp2416548
– https://health.ucdavis.edu/internal-medicine/team/42806/angel-desai-infectious-diseases-sacramento-sacramento
– https://www.cdc.gov/one-health/about/index.html
– https://www.epa.gov/pesticides/epa-finalizes-framework-interagency-collaboration-resistance-risks-associated
– https://health.ucdavis.edu/news/headlines/cdc-issues-warning-about-increase-of-drug-resistant-candida-auris-infections/2023/03

References:
Thompson, G. R., Desai, A. Commentary: Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge. New England Journal of Medicine, June 7, 2025. DOI: 10.1056/NEJMp2416548

Keywords: Infectious diseases, Antifungal resistance, One Health, Candida auris, Pesticide regulation, Fungal pathogens, Antimicrobial stewardship, Environmental health

Delving into precision health, the upcoming school aims to gather a diverse group of international experts, ranging from academia to the forefront of health technology startups. This convergence of knowledge and innovation is designed to facilitate the exchange of groundbreaking ideas and practices that can significantly advance the field. By discussing the latest research outcomes and innovative methodologies, participants will be able to explore the integration of various scientific disciplines, enhancing their understanding of precision health and its applications.

A considerable aspect of the program is the involvement of world-class scientists who have made notable contributions to their respective fields. Prominent speakers, such as Alexander Birbrair from the University of Wisconsin-Madison, will share insights from his work focused on developing novel therapeutic targets for cancer treatment. His research advocates for an innovative approach to oncology, emphasizing the importance of cellular and molecular pathways as potential interventions.

Additionally, David John Argyle, an esteemed figure in veterinary oncology from the University of Glasgow, will contribute his expertise in cancer biology and comparative oncology. His perspective will enrich discussions surrounding both veterinary and human medicine’s shared challenges, offering collaborative solutions that leverage lessons learned from both spheres. The collaborative spirit of the school reflects a broader trend in contemporary scientific research, emphasizing inter-disciplinary connections as catalysts for innovation.

Chiara Palmieri from the University of Queensland will also participate, co-leading discussions pertaining to veterinary cancer surveillance. Her role as a co-coordinator of the Global Initiative for Veterinary Cancer Surveillance (GIVCS) underlines the necessity for standardized practices and data collection in veterinary settings, which can greatly influence subsequent research and application in both human and animal health contexts. Her participation will spark discussions focused on harmonizing veterinary and human medical practices to optimize outcomes for both fields.

Students attending the São Paulo School of Advanced Science will have access to an immersive learning environment where they can participate in intensive discussions, workshops, and networking opportunities. The format is designed not only to provide education but also to build connections that may yield future collaboration. Attendees will have the unique opportunity to present their research in small group settings, fostering a communicative atmosphere that encourages peer feedback and engagement.

This initiative is backed by the São Paulo Research Foundation (FAPESP), which has a longstanding commitment to promoting scientific excellence and innovation. Through its São Paulo School of Advanced Science Program (SPSAS), FAPESP invites promising Master’s and Ph.D. students, as well as early career researchers from around the globe, to apply for the program at no cost. By offering full financial support for selected participants, the program demonstrates its dedication to nurturing the next generation of scientific leaders.

Applications are currently open for prospective attendees until March 17, 2025, and candidates are encouraged to fill out an application form available on the School’s official website. The curatorial team aims to select 100 students, creating a balanced cohort of scholars from Brazilian institutions and international counterparts, further enriching the collaborative potential of the gathering. The diversity of the participants will undoubtedly enhance the educational experience, allowing for broader perspectives and innovative contributions to the discussions.

FAPESP, a proactive public institution, seeks to foster scientific research across a plethora of disciplines. By providing scholarships, fellowships, and grants, they ensure that researchers in São Paulo have the opportunity to engage in groundbreaking projects. This mission aligns perfectly with the goals of the São Paulo School of Advanced Science, as it aims to cultivate the foundational knowledge needed for addressing complex health issues through precision medicine.

Beyond scientific collaboration, the discussions at the school will also challenge participants to think critically about the implications of precision health on a global scale. The One Health approach, which emphasizes interconnectedness among human, animal, and environmental health, will serve as a guiding framework for discourse throughout the program. This perspective is increasingly vital in an era defined by the globalization of health issues, where diseases can jump between species, necessitating a holistic approach to health management.

The school’s emphasis on innovative thought leadership and contemporary research methodologies positions it as a pivotal gathering in the scientific calendar. By integrating experts from varied specializations, the program promises to elevate the discourse surrounding precision health, ultimately contributing to transformative outcomes in both veterinary and human medicine. Participants will leave with enhanced skill sets, new collaborations, and inspiration to advance their own research efforts in meaningful ways.

Through the lens of fostering scientific communication and collaboration, the São Paulo School of Advanced Science in Precision Health presents an exciting opportunity for researchers at all stages of their careers. The skills honed and connections made during this event could potentially ripple out to influence global health initiatives, making a significant impact on how we understand and approach complex health challenges moving forward.

As the school approaches, the anticipation continues to build among stakeholders eager to contribute to the advancements in precision health. This confluence of talent, experience, and vision sets the stage for revolutionary ideas that could advance public health initiatives and clinical practices. The outcomes of this school will likely resonate well beyond its conclusion, shaping the future of veterinary and human medicine alike.

Subject of Research: Precision Health and One Health Approach
Article Title: São Paulo School of Advanced Science on Precision Health to Facilitate Global Scientific Collaboration
News Publication Date: October 2023
Web References: FAPESP
References: None
Image Credits: SPSAS

Keywords: Precision Health, One Health, Veterinary Medicine, Oncology, FAPESP, Scientific Collaboration, Global Health